Centessa Pharmaceuticals plc
CNTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$235,757 | -$151,085 | -$216,207 | -$381,854 |
| Dep. & Amort. | $942 | $810 | $131 | $34 |
| Deferred Tax | $2,653 | -$26,632 | -$2,857 | $0 |
| Stock-Based Comp. | $33,546 | $29,392 | $24,965 | $0 |
| Change in WC | $22,102 | -$18,858 | -$2,831 | -$5,378 |
| Other Non-Cash | $34,459 | $6,031 | -$3,747 | $251,057 |
| Operating Cash Flow | -$142,055 | -$160,342 | -$200,546 | -$136,142 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$34 | -$169 | -$1,137 | -$186 |
| Net Acquisitions | $0 | $0 | $0 | $63,434 |
| Inv. Purchases | -$140,533 | -$264,910 | $0 | $0 |
| Inv. Sales/Matur. | $171,834 | $138,075 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $206 | $0 |
| Investing Cash Flow | $31,267 | -$127,004 | -$931 | $63,248 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$762 | $0 | $0 | $73,638 |
| Stock Issued | $359,605 | $20,807 | $0 | $586,442 |
| Stock Repurch. | $0 | $0 | $0 | -$12 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,909 | $310 | $457 | $0 |
| Financing Cash Flow | $364,752 | $21,117 | $457 | $660,068 |
| Forex Effect | $1,227 | $615 | -$418 | $2,904 |
| Net Chg. in Cash | $255,191 | -$265,614 | -$201,438 | $590,079 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $128,030 | $393,644 | $595,082 | $5,003 |
| End Cash | $383,221 | $128,030 | $393,644 | $595,082 |
| Free Cash Flow | -$142,089 | -$160,511 | -$201,683 | -$136,328 |